Nov 8, 2022 | health policy, oncopolicy |
this article was originally published on the macdonald laurier laurier institute blog by W. Neil Palmer on November 1.2022 and republished here. The Patented Medicine Prices Review Board (PMPRB) is once again attracting the ire of the life sciences industry and...
Nov 2, 2020 | oncopolicy, precision medicine |
throughout the month of november, the cancer collaborative in collaboration with the european cancer patients coalition [ECPC] will highlight the growing role that precision medicine plays in oncology through the CRACKING THE CANCER CODE campaign. the premise of...
Jan 13, 2020 | biosimilars, health policy, oncology, oncopolicy |
last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost...
